15.01
price down icon9.20%   -1.52
pre-market  Vorhandelsmarkt:  15.30   0.29   +1.93%
loading
Schlusskurs vom Vortag:
$16.53
Offen:
$16.46
24-Stunden-Volumen:
1.55M
Relative Volume:
1.14
Marktkapitalisierung:
$798.94M
Einnahmen:
$312.78M
Nettoeinkommen (Verlust:
$-143.56M
KGV:
-5.5799
EPS:
-2.69
Netto-Cashflow:
$1.22M
1W Leistung:
+3.73%
1M Leistung:
+0.33%
6M Leistung:
+5.85%
1J Leistung:
-35.33%
1-Tages-Spanne:
Value
$14.58
$16.46
1-Wochen-Bereich:
Value
$14.27
$16.60
52-Wochen-Spanne:
Value
$10.96
$26.37

Caredx Inc Stock (CDNA) Company Profile

Name
Firmenname
Caredx Inc
Name
Telefon
415-287-2300
Name
Adresse
8000 MARINA BLVD, BRISBANE, CA
Name
Mitarbeiter
650
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
CDNA's Discussions on Twitter

Vergleichen Sie CDNA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
CDNA
Caredx Inc
15.01 850.18M 312.78M -143.56M 1.22M -2.69
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
565.98 213.27B 43.74B 6.58B 6.11B 17.31
Diagnostics & Research icon
DHR
Danaher Corp
210.67 149.89B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
713.74 57.51B 4.17B 1.03B 940.22M 12.61
Diagnostics & Research icon
A
Agilent Technologies Inc
147.49 41.61B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
210.86 35.78B 15.90B 1.28B 2.21B 7.2842

Caredx Inc Stock (CDNA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-26 Eingeleitet William Blair Mkt Perform
2025-01-15 Hochstufung Wells Fargo Underweight → Equal Weight
2024-08-28 Eingeleitet Wells Fargo Underweight
2024-08-19 Hochstufung BTIG Research Neutral → Buy
2024-05-13 Herabstufung Raymond James Outperform → Mkt Perform
2024-05-01 Hochstufung Craig Hallum Hold → Buy
2023-11-09 Hochstufung Stephens Equal-Weight → Overweight
2023-08-15 Hochstufung Raymond James Mkt Perform → Outperform
2023-05-11 Herabstufung BTIG Research Buy → Neutral
2023-03-07 Herabstufung Stephens Overweight → Equal-Weight
2023-03-03 Herabstufung Craig Hallum Buy → Hold
2023-03-03 Herabstufung Raymond James Strong Buy → Mkt Perform
2022-04-25 Eingeleitet Stephens Overweight
2021-07-20 Fortgesetzt BTIG Research Buy
2021-06-03 Eingeleitet Goldman Buy
2021-02-26 Herabstufung H.C. Wainwright Buy → Neutral
2020-10-30 Bestätigt H.C. Wainwright Buy
2020-10-08 Bestätigt H.C. Wainwright Buy
2020-10-02 Bestätigt H.C. Wainwright Buy
2020-08-05 Bestätigt H.C. Wainwright Buy
2020-06-26 Eingeleitet BTIG Research Buy
2020-06-19 Bestätigt H.C. Wainwright Buy
2019-10-01 Fortgesetzt Craig Hallum Buy
2019-05-09 Hochstufung H.C. Wainwright Neutral → Buy
2019-02-15 Eingeleitet Jefferies Buy
2018-10-23 Fortgesetzt Raymond James Strong Buy
2018-09-18 Bestätigt H.C. Wainwright Neutral
2017-11-27 Eingeleitet H.C. Wainwright Buy
2016-06-14 Bestätigt Mizuho Buy
2015-09-29 Herabstufung Raymond James Outperform → Mkt Perform
2015-09-25 Eingeleitet Craig Hallum Buy
2015-03-18 Bestätigt Mizuho Buy
Alle ansehen

Caredx Inc Aktie (CDNA) Neueste Nachrichten

pulisher
01:56 AM

CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025 - BioSpace

01:56 AM
pulisher
Nov 06, 2025

Why CareDx Inc (1K9) stock remains stableMarket Trend Summary & Verified Entry Point Detection - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

What is the fair value estimate for CareDx Inc (1K9) stock in 2025Market Movement Recap & Low Risk Investment Opportunities - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

CareDx, Inc. Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025 - MarketScreener

Nov 06, 2025
pulisher
Nov 06, 2025

Trend analysis for CareDx Inc this weekCEO Change & Weekly Momentum Picks - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

CareDx, Inc (NASDAQ:CDNA) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 06, 2025
pulisher
Nov 06, 2025

BTIG Maintains CareDx (CDNA) Buy Recommendation - Nasdaq

Nov 06, 2025
pulisher
Nov 06, 2025

3 Analysts Have This To Say About CareDx - Benzinga

Nov 06, 2025
pulisher
Nov 06, 2025

CDNA: BTIG Raises Price Target to $25, Maintains Buy Rating | CD - GuruFocus

Nov 06, 2025
pulisher
Nov 06, 2025

Is CareDx Inc stock trading near support levelsPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Is CareDx Inc stock a top momentum playQuarterly Trade Review & Stepwise Trade Execution Plans - fcp.pa.gov.br

Nov 06, 2025
pulisher
Nov 05, 2025

Will CareDx Inc stock maintain dividend yieldQuarterly Profit Report & Free Real-Time Market Sentiment Alerts - fcp.pa.gov.br

Nov 05, 2025
pulisher
Nov 05, 2025

Will CareDx Inc stock outperform international peers2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

CareDx (CDNA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - sharewise.com

Nov 05, 2025
pulisher
Nov 05, 2025

CareDx (CDNA) Surpasses Q3 Earnings and Revenue Estimates - sharewise.com

Nov 05, 2025
pulisher
Nov 05, 2025

What Fibonacci levels say about CareDx Inc rebound2025 Short Interest & High Accuracy Trade Signal Alerts - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

CareDx (CDNA) Turns Profitable on $89.4M One-Off Gain, Challenging Quality of Earnings Narrative - Yahoo Finance

Nov 05, 2025
pulisher
Nov 05, 2025

CareDx Inc. Reports Strong Q3 Earnings Growth - TipRanks

Nov 05, 2025
pulisher
Nov 05, 2025

CareDx (NASDAQ:CDNA) Releases Quarterly Earnings Results - MarketBeat

Nov 05, 2025
pulisher
Nov 05, 2025

CareDx raises 2025 revenue guidance to $372M–$376M with robust RCM gains and new product launches - MSN

Nov 05, 2025
pulisher
Nov 05, 2025

CareDx Q3 2025 presentation slides: Revenue up 21%, guidance raised despite market caution By Investing.com - Investing.com South Africa

Nov 05, 2025
pulisher
Nov 05, 2025

Caredx Inc earnings beat by $0.36, revenue topped estimates - Investing.com Australia

Nov 05, 2025
pulisher
Nov 05, 2025

CareDx Q3 2025 presentation slides: Revenue up 21%, guidance raised despite market caution - Investing.com Australia

Nov 05, 2025
pulisher
Nov 05, 2025

Why CareDx Inc stock is trending among retail tradersTrend Reversal & Weekly High Return Stock Forecasts - fcp.pa.gov.br

Nov 05, 2025
pulisher
Nov 05, 2025

Applying sector rotation models to CareDx IncChart Signals & Entry Point Confirmation Alerts - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

CareDx: Q3 Earnings Snapshot - CT Insider

Nov 05, 2025
pulisher
Nov 05, 2025

CareDx Inc (CDNA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance By GuruFocus - Investing.com Canada

Nov 05, 2025
pulisher
Nov 05, 2025

Detecting price anomalies in CareDx Inc with AIVolume Spike & Free Risk Controlled Daily Trade Plans - newser.com

Nov 05, 2025
pulisher
Nov 04, 2025

CareDx Reports Strong Q3 2025 Financial Results - TipRanks

Nov 04, 2025
pulisher
Nov 04, 2025

CareDx Outpaces Expectations And Raises Its 2025 Outlook - Finimize

Nov 04, 2025
pulisher
Nov 04, 2025

Earnings call transcript: CareDx Q3 2025 revenue beats forecast, stock dips By Investing.com - Investing.com South Africa

Nov 04, 2025
pulisher
Nov 04, 2025

Transcript : CareDx, Inc, Q3 2025 Earnings Call, Nov 04, 2025 - MarketScreener

Nov 04, 2025
pulisher
Nov 04, 2025

Earnings call transcript: CareDx Q3 2025 revenue beats forecast, stock dips - Investing.com

Nov 04, 2025
pulisher
Nov 04, 2025

CareDx Inc (CDNA) Q3 2025 Earnings: EPS of $0.03 Beats Estimate, - GuruFocus

Nov 04, 2025
pulisher
Nov 04, 2025

Transplant diagnostics firm CareDx Q3 revenue beats estimates, helped by new product launches - MarketScreener

Nov 04, 2025
pulisher
Nov 04, 2025

CareDx Reports Strong Q3 Financial Results - TipRanks

Nov 04, 2025
pulisher
Nov 04, 2025

CareDx Announces Third Quarter 2025 Financial Results - The Joplin Globe

Nov 04, 2025
pulisher
Nov 03, 2025

Can you recover from losses in CareDx IncTrade Ideas & High Accuracy Swing Entry Alerts - newser.com

Nov 03, 2025

Finanzdaten der Caredx Inc-Aktie (CDNA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research DGX
$176.51
price down icon 0.98%
diagnostics_research LH
$246.64
price down icon 1.62%
diagnostics_research WAT
$371.16
price down icon 0.22%
$198.48
price down icon 0.72%
diagnostics_research MTD
$1,439.62
price down icon 0.01%
diagnostics_research IQV
$210.86
price up icon 0.35%
Kapitalisierung:     |  Volumen (24h):